Bayer Sidelines Essure Concerns as Anecdotal, Legal Claims Build Up

A week post Bayer’s announcement on the withdrawal of Essure, its contraceptive implant from the market by this year-end due to inadequate sales, its clinical safety is questioned as consumer and legal stress builds up concerning complaints of extreme fatigue, pain and bleeding.

• Source: FierceBiotech
• 534
• July 30, 2018